Trial site
Formed 2 Sp. z o.o.
Oswiecim, 32-600, PolandEU-13 widening countryNot linked to an institution yet
- 9running trials
- 2closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Phase
- Phase 26 trials
- Phase 35 trials
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Completed2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Novo Nordisk A/S9 trials
- Maia Biotechnology1 trial
- Novartis Pharmaceuticals1 trial
Running trials
Not yet recruiting
A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
NCT07931495· Phase 3· Novo Nordisk A/S· Source
Not yet recruiting
A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or Both
NCT07931547· Phase 3· Novo Nordisk A/S· Source
Not yet recruiting
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
NCT07861100· Phase 3· Novo Nordisk A/S· Source
Recruiting
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
NCT07668388· Phase 2· Novo Nordisk A/S· Source
Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
NCT07415954· Phase 2· Novo Nordisk A/S· Source
Active, not recruiting
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
NCT07076199· Phase 3· Novo Nordisk A/S· Source
Active, not recruiting
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
NCT06991556· Phase 2· Novartis Pharmaceuticals· Source
Active, not recruiting
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation
NCT06200207· Phase 3· Novo Nordisk A/S· Source
Active, not recruiting
THIO Sequenced With Cemiplimab in Advanced NSCLC
NCT05208944· Phase 2· Maia Biotechnology· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error